NCBI LogoThe article “Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes” provides an in depth look a variety of, what are typically considered, treatment-resistant issues and the potential role of endocannabinoids regarding these issues.

This article further discusses the initial proposal of the theory of endocannabinoid deficiency along with the lack of to back the theory when initially proposed, which is followed up by more current data and statistics which seems to suggest a link and possibly support the theory. Definitely an interesting read.

Read the full review on the NCBI website>>